QQ客服 官方微博 反馈留言

浏览/检索结果: 共36条，第1-10条 帮助 限定条件 发表日期：2017    专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease: A meta-analysis [Wirkungen von Paricalcitol auf kardiovaskuläre Ergebnisse und Nierenfunktion bei Patienten mit chronischer Nierenerkrankung: Eine Metaanalyse] 期刊论文 Herz, 2017, 页码: 1-11 作者:  Hu, X;  Shang, J;  Yuan, W;  Zhang, S;  Jiang, Y 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 Glomerular filtration rate  Hypercalcemia  Proteinuria  Serum creatinine  Vitamin D receptor   Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma 期刊论文 THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 卷号: 10, 期号: 2, 页码: 231-241 作者:  Zhao, Qianqian;  Xu, Xiaoqing;  Yue, Jinbo;  Zhu, Kunli;  Feng, Rui 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/16 clinical outcomes  hepatocellular carcinoma  minimum absolute lymphocyte  counts  prognostic  radiotherapy   Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors 期刊论文 MEDICINE, 2017, 卷号: 96, 期号: 33 作者:  Gao, Zhendong;  Du, Gang;  Pang, Yuguang;  Fu, Zhihao;  Liu, Chongzhong 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/16 disease-free survival  hepatocellular carcinoma  overall survival  radical resection  recurrence  transarterial chemoembolization   A meta-analysis of soluble suppression of tumorigenicity 2 （sST2） and clinical outcomes in pulmonary hypertension 期刊论文 老年心脏病学杂志：英文版, 2017, 期号: 12 作者:  King Sum Luk[1,2];  Christina Ip[1,2];  Meng-Qi GONG[3];  Sunny Hei WONG[1,2];  William KK Wu[2,4] 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 高血压  临床  膜受体  ST2  IL-1  肺  免疫力  家庭   Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases 期刊论文 慢性疾病与转化医学：英文版, 2017, 期号: 04 作者:  Ling-Ling Kong;  Lin-Lin Wang;  Li-Gang Xing;  Jin-Ming Yu 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 Long-term outcomes of stage I NSCLC (<= 3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis 期刊论文 JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 11, 页码: 4561-+ 作者:  Qu, Xiao;  Wang, Kai;  Zhang, Tiehong;  Shen, Hongchang;  Dong, Wei 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 Segmentectomy  lobectomy  non-small cell lung cancer (NSCLC)  prognosis  lymph nodes (LN)   Long-term outcomes of minimally invasive Ivor Lewis esophagostomy for esophageal squamous cell carcinoma: Compared with open approach 期刊论文 INTERNATIONAL JOURNAL OF SURGERY, 2017, 卷号: 45, 页码: 98-104 作者:  Zhang, Zhenghua;  Xu, Meiqing;  Guo, Mingfa;  Liu, Xuegang 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 Esophageal squamous cell carcinoma  Thoracoscopy  Laparoscopy  Ivor  Lewis esophagostomy   Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer 期刊论文 ONCOLOGY LETTERS, 2017, 卷号: 13, 期号: 6, 页码: 4469-4474 作者:  Liu, Jin;  Wang, Chuifang;  Liu, Xiangyan;  Wang, Yu;  Liu, Haibo 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 miR-1469  progression  relapse  prognosis  esophageal squamous cell  cancer   Chinese systemic lupus erythematosus treatment and research group registry IX: Clinical features and survival of childhood-onset systemic lupus erythematosus in china 期刊论文 Chinese Medical Journal, 2017, 卷号: 130, 期号: 11, 页码: 1276-1282 作者:  Wu C.-Y.;  Li C.-F.;  Wu Q.-J.;  Xu J.-H.;  Jiang L.-D. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 Childhood Onset  Outcomes  Systemic Lupus Erythematosus   Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China 期刊论文 BMC INFECTIOUS DISEASES, 2017, 卷号: 17 作者:  He, Xiao-chun;  Tao, Ning-ning;  Liu, Yao;  Zhang, Xian-xin;  Li, Huai-chen 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 XDR-TB  Epidemiology trends  Treatment outcomes  Survival